Imagine visiting your primary care doctor and receiving a whole read out of your genomic data within 10 minutes for as little as $10, equipping your doctor with the information needed in order to deliver you individually tailored medical treatments and therapies. Thanks to the work being done at Roswell Biotechnologies, this is well on its way to becoming a reality.

As the founder, president, and CEO of Roswell Biotechnologies, Paul Mola realizes the need to sequence genomes at scale in order to obtain the level of understanding and interpretation needed for making precision medicine a reality. What we really need, he says, is a “genomic encyclopedia” of genetic variances and corresponding phenotypic descriptions, treatments, and drug therapies. Until now, the high cost and slow process of genomic sequencing has stymied this development and kept enormous amounts of useful information largely inaccessible and unaffordable for the average person.

Mola has discovered a viable solution by merging nanochemistry with CMOS technology (which is the same technology that’s used to manufacture computer chips), which allows for direct electronic monitoring of the process by which DNA is copied. It’s time-saving, cost-effective, and scalable, and there’s nothing else like it out there. Rather than taking 24 hours and costing $1,500 to sequence a genome, the Roswell solution will take just an hour and cost $100, and packs a ton of opportunities for improvement down the road.